| miR-615-5p acts as tumor-suppressor in hepatocellular carcinoma through targeting IGF-II. | liver, |
| CDX2 inhibited pancreatic adenocarcinoma cell proliferation via promoting tumor suppressor miR-615-5p. Our findings suggested a potential molecular target for pancreatic adenocarcinoma therapy. | pancreatic, |
| miR-615-5p, is downregulated by KDM4B-mediated hypermethylation in its promoter, functions as a tumor suppressor by inhibiting RAB24 expression in hepatocellular carcinoma. miR-615-5p is an important epigenetically silenced miRNA involved in the Rab-Ras pathway in hepatocellular carcinoma. | liver, |
| Identification of microRNA-615-3p as a novel tumor suppressor in non-small cell lung cancer | lung, |
| LncRNA Gm15290 Promotes Cell Proliferation and Invasion in Non-Small Cell Lung Cancer Through Directly Interacting With and Suppressing the Tumor Suppressor miR-615-5p | lung, |
| MiR-615 as a tumor suppressor by targeting cyclin D2 in prostate cancer. | prostate, |
| miR-615 plays a tumor suppressor role in glioblastoma cell proliferation, migration and invasion by targeting EGFR expression. | glioblastoma, |
| Long non-coding RNA Gm15290 promotes cell proliferation and invasion in lung cancer through directly interacting with and suppressing the tumor suppressor miR-615-5p. | lung, |
| MicroRNA-615 functions as a tumor suppressor in osteosarcoma through the suppression of HK2 | osteosarcoma, |
| Overexpression of CELF2 could reverse miR-615-3p_s oncogenic functions. | None |